School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Sujin Lee PhD

  • Department of Pediatrics
    Assistant Professor
  • (404) 712-1637
  • sujin.lee@emory.edu
Head shot of Sujin Lee

Academic Appointment

  • Assistant Professor, Department of Pediatrics, Emory University School of Medicine

Education

Degrees

  • PhD from University of Tennessee

Research

Publications

  • Combating yellow fever virus with 7-deaza-7-fluoro-2'-C-methyladenosine.
    Antimicrob Agents Chemother Volume: 69 Page(s): e0188924
    05/07/2025 Authors: LeCher JC; Costa VV; Rust LN; Bassit LC; Patel D; Rezaei S; Moua J; Santos FRDS; Goncalves MR; Queroz-Junior CM
  • A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose.
    NPJ Vaccines Volume: 9 Page(s): 255
    12/23/2024 Authors: Rostad CA; Yildirim I; Kao C; Yi J; Kamidani S; Peters E; Stephens K; Gibson T; Hsiao H-M; Singh K
  • Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization.
    J Med Virol Volume: 95 Page(s): e29058
    08/01/2023 Authors: Bochkov YA; Devries M; Tetreault K; Gangnon R; Lee S; Bacharier LB; Busse WW; Camargo CA; Choi T; Cohen R
  • Discovery of a 2'-Fluoro,2'-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice.
    Microorganisms Volume: 10
    10/22/2022 Authors: LeCher JC; Zandi K; Costa VV; Amblard F; Tao S; Patel D; Lee S; da Silva Santos FR; Goncalves MR; Queroz-Junior CM
  • Relationship between blood type and outcomes following COVID-19 infection.
    Semin Vasc Surg Volume: 34 Page(s): 125 - 131
    09/01/2021 Authors: Kim Y; Latz CA; DeCarlo CS; Lee S; Png CYM; Kibrik P; Sung E; Alabi O; Dua A
  • A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    J Virol Volume: 95
    12/22/2020 Authors: Human S; Hotard AL; Rostad CA; Lee S; McCormick L; Larkin EK; Peret TCT; Jorba J; Lanzone J; Gebretsadik T
  • Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.
    Vaccine Volume: 37 Page(s): 6656 - 6664
    10/16/2019 Authors: Kwon Y-M; Lee Y; Kim KH; Jung YJ; Li Z; Jeeva S; Lee S; Moore ML; Kang S-M
  • Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
    Antimicrob Agents Chemother Volume: 62
    08/01/2018 Authors: Yoon J-J; Toots M; Lee S; Lee M-E; Ludeke B; Luczo JM; Ganti K; Cox RM; Sticher ZM; Edpuganti V
  • The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.
    J Vasc Surg Volume: 68 Page(s): 536 - 545.e2
    08/01/2018 Authors: Arya S; Lee S; Zahner GJ; Cohen BE; Hiramoto J; Wolkowitz OM; Khakharia A; Binney ZO; Grenon SM
  • Generating Neutralizing Antibody responses using Recombinant Infectious Rhinovirus
    Volume: 200
    05/01/2018 Authors: Lee S; Tang R; Currier M; Moore M
  • Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues.
    J Virol Volume: 92
    03/15/2018 Authors: Rostad CA; Stobart CC; Todd SO; Molina SA; Lee S; Blanco JCG; Moore ML
  • Immunogenicity of 50-Valent Rhinovirus Vaccine
    Volume: 139 Page(s): AB376 - AB376
    02/01/2017 Authors: Lee S; Nguyen MT; Currier MG; Jenkins JB; Strobert EA; Kajon AE; Madan-Lala R; Bochkov YA; Gern JE; Roy K
  • Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.
    Cancer Immunol Res Volume: 5 Page(s): 72 - 83
    01/01/2017 Authors: Kumai T; Lee S; Cho H-I; Sultan H; Kobayashi H; Harabuchi Y; Celis E
  • A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.
    Nat Commun Volume: 7 Page(s): 13916
    12/21/2016 Authors: Stobart CC; Rostad CA; Ke Z; Dillard RS; Hampton CM; Strauss JD; Yi H; Hotard AL; Meng J; Pickles RJ
  • A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques.
    Nat Commun Volume: 7 Page(s): 12838
    09/22/2016 Authors: Lee S; Nguyen MT; Currier MG; Jenkins JB; Strobert EA; Kajon AE; Madan-Lala R; Bochkov YA; Gern JE; Roy K
  • EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression.
    PLoS Pathog Volume: 12 Page(s): e1005622
    05/01/2016 Authors: Currier MG; Lee S; Stobart CC; Hotard AL; Villenave R; Meng J; Pretto CD; Shields MD; Nguyen MT; Todd SO
  • Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    J Virol Volume: 90 Page(s): 245 - 253
    01/01/2016 Authors: Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
  • Recent advances of vaccine adjuvants for infectious diseases.
    Immune Netw Volume: 15 Page(s): 51 - 57
    04/01/2015 Authors: Lee S; Nguyen MT
  • Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.
    J Virol Volume: 89 Page(s): 512 - 522
    01/01/2015 Authors: Hotard AL; Lee S; Currier MG; Crowe JE; Sakamoto K; Newcomb DC; Peebles RS; Plemper RK; Moore ML
  • Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.
    Nanomedicine Volume: 11 Page(s): 99 - 108
    01/01/2015 Authors: Ko E-J; Kwon Y-M; Lee JS; Hwang HS; Yoo S-E; Lee Y-N; Lee Y-T; Kim M-C; Cho MK; Lee YR
  • Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
    Antiviral Res Volume: 111 Page(s): 129 - 135
    11/01/2014 Authors: Lee S; Quan F-S; Kwon Y; Sakamoto K; Kang S-M; Compans RW; Moore ML
  • Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes.
    mBio Volume: 5 Page(s): e01704 - e01714
    09/23/2014 Authors: Meng J; Lee S; Hotard AL; Moore ML
  • Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.
    Proc Natl Acad Sci U S A Volume: 111 Page(s): E3441 - E3449
    08/19/2014 Authors: Yan D; Lee S; Thakkar VD; Luo M; Moore ML; Plemper RK
  • Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.
    Antiviral Res Volume: 104 Page(s): 1 - 6
    04/01/2014 Authors: Kwon Y-M; Hwang HS; Lee JS; Ko E-J; Yoo S-E; Kim M-C; Lee Y-N; Kim K-H; Song J-M; Lee S
  • Epidermal Growth Factor Receptor (EGFR) Mediates Cell Fusion and Infectivity Of Respiratory Syncytial Virus (RSV)
    Volume: 133 Page(s): AB71 - AB71
    02/01/2014 Authors: Lee S; Currier MG; Hotard AL; Meng J; Pretto C; Power UF; Villenave R; Shields MD; Chi MH; Peebles RS
  • Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.
    J Immunol Volume: 192 Page(s): 293 - 299
    01/01/2014 Authors: Lee S; Mittler RS; Moore ML
  • The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
    J Virol Volume: 87 Page(s): 10070 - 10082
    09/01/2013 Authors: Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
  • Analysis of bronchoalveolar immune cells and cytokines induced by immunization with different respiratory syncytial virus vaccines
    Volume: 190
    05/01/2013 Authors: Ko E-J; Lee JS; Lee Y-N; Kwon Y-M; Hwang HS; Yoo S-E; Quan F-S; Lee S; Moore M; Kang S-M
  • Enhancement of vaccine-induced respiratory syncytial virus-specific memory CD8 T cell responses by targeting 41BB
    Volume: 190
    05/01/2013 Authors: Lee S; Moore M
  • A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.
    Virology Volume: 434 Page(s): 129 - 136
    12/05/2012 Authors: Hotard AL; Shaikh FY; Lee S; Yan D; Teng MN; Plemper RK; Crowe JE; Moore ML
  • Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.
    J Virol Volume: 86 Page(s): 13016 - 13024
    12/01/2012 Authors: Lee S; Stokes KL; Currier MG; Sakamoto K; Lukacs NW; Celis E; Moore ML
  • An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice.
    Immun Ageing Volume: 9 Page(s): 21
    10/02/2012 Authors: Cherukuri A; Stokes KL; Patton K; Kuo H; Sakamoto K; Lambert S; Stillman E; Moore ML; Lee S
  • Vaccine-elicited CD8+T cells protect against respiratory syncytial virus-induced lung airway obstruction
    Volume: 188
    05/01/2012 Authors: Lee S; Stokes K; Celis E; Moore M
  • Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
    J Infect Dis Volume: 204 Page(s): 987 - 995
    10/01/2011 Authors: Quan F-S; Kim Y; Lee S; Yi H; Kang S-M; Bozja J; Moore ML; Compans RW
  • Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.
    J Virol Volume: 85 Page(s): 5782 - 5793
    06/01/2011 Authors: Stokes KL; Chi MH; Sakamoto K; Newcomb DC; Currier MG; Huckabee MM; Lee S; Goleniewska K; Pretto C; Williams JV
  • Genome-wide detection of a TFIID localization element from an initial human disease mutation.
    Nucleic Acids Res Volume: 39 Page(s): 2175 - 2187
    03/01/2011 Authors: Yang MQ; Laflamme K; Gotea V; Joiner CH; Seidel NE; Wong C; Petrykowska HM; Lichtenberg J; Lee S; Welch L
  • Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors.
    Cancer Immunol Immunother Volume: 59 Page(s): 1073 - 1081
    07/01/2010 Authors: Lee S; Yagita H; Sayers TJ; Celis E
  • Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival.
    Cancer Res Volume: 70 Page(s): 1173 - 1183
    02/01/2010 Authors: Kang SS; Han K-S; Ku BM; Lee YK; Hong J; Shin HY; Almonte AG; Woo DH; Brat DJ; Hwang EM
  • Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.
    Vaccine Volume: 26 Page(s): 4775 - 4782
    09/02/2008 Authors: Mok H; Lee S; Wright DW; Crowe JE
  • Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.
    J Virol Volume: 81 Page(s): 13710 - 13722
    12/01/2007 Authors: Mok H; Lee S; Utley TJ; Shepherd BE; Polosukhin VV; Collier ML; Davis NL; Johnston RE; Crowe JE
  • Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
    J Virol Volume: 81 Page(s): 2349 - 2358
    03/01/2007 Authors: Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
  • Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
    J Leukoc Biol Volume: 80 Page(s): 1405 - 1415
    12/01/2006 Authors: Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT
  • Application of FGF-2 to modulate herpetic stromal keratitis.
    Curr Eye Res Volume: 31 Page(s): 1021 - 1028
    12/01/2006 Authors: Kim B; Lee S; Kaistha SD; Rouse BT
  • Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.
    J Immunol Volume: 177 Page(s): 4122 - 4131
    09/15/2006 Authors: Kim B; Suvas S; Sarangi PP; Lee S; Reisfeld RA; Rouse BT
  • Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.
    J Immunol Volume: 175 Page(s): 509 - 516
    07/01/2005 Authors: Kim B; Lee S; Suvas S; Rouse BT
  • CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
    J Immunol Volume: 172 Page(s): 1237 - 1245
    01/15/2004 Authors: Banerjee K; Biswas PS; Kim B; Lee S; Rouse BT
  • CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.
    J Exp Med Volume: 198 Page(s): 889 - 901
    09/15/2003 Authors: Suvas S; Kumaraguru U; Pack CD; Lee S; Rouse BT
  • Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus.
    Microbes Infect Volume: 5 Page(s): 571 - 578
    06/01/2003 Authors: Lee S; Gierynska M; Eo SK; Kuklin N; Rouse BT
  • Topical administration of plasmid-encoded monocyte chemoattractant protein-1 reduces severity of herpetic stromal keratitis by enhancing Th2 responses
    Volume: 17 Page(s): C20 - C20
    04/14/2003 Authors: Kim B; Lee S; Lee Y; Rouse BT
  • Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
    J Clin Invest Volume: 110 Page(s): 1105 - 1111
    10/01/2002 Authors: Lee S; Zheng M; Kim B; Rouse BT
  • Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.
    J Virol Volume: 76 Page(s): 6568 - 6576
    07/01/2002 Authors: Gierynska M; Kumaraguru U; Eo S-K; Lee S; Krieg A; Rouse BT
  • Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions.
    Vet Microbiol Volume: 86 Page(s): 17 - 26
    04/22/2002 Authors: Deshpande SP; Zheng M; Lee S; Rouse BT
  • On the role of MMP-9 in the HSK pathogenesis
    FASEB JOURNAL Volume: 16 Page(s): A1042 - A1042
    03/22/2002 Authors: Lee SJ; Zheng M; Rouse BT
  • CD8+response induced by CpG-peptide may probably require CD4 help for maintenance.
    FASEB JOURNAL Volume: 16 Page(s): A680 - A680
    03/20/2002 Authors: Gierynska M; Kumaraguru U; Lee SJ; Rouse BT
  • IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis.
    J Leukoc Biol Volume: 71 Page(s): 469 - 476
    03/01/2002 Authors: Lee S; Zheng M; Deshpande S; Eo SK; Hamilton TA; Rouse BT
  • Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.
    J Virol Volume: 75 Page(s): 9828 - 9835
    10/01/2001 Authors: Zheng M; Deshpande S; Lee S; Ferrara N; Rouse BT
  • Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
    Vaccine Volume: 19 Page(s): 4685 - 4693
    09/14/2001 Authors: Eo SK; Lee S; Kumaraguru U; Rouse BT
  • Control of stromal keratitis by inhibition of neovascularization.
    Am J Pathol Volume: 159 Page(s): 1021 - 1029
    09/01/2001 Authors: Zheng M; Schwarz MA; Lee S; Kumaraguru U; Rouse BT
  • Bystander activation involving T lymphocytes in herpetic stromal keratitis.
    J Immunol Volume: 167 Page(s): 2902 - 2910
    09/01/2001 Authors: Deshpande S; Zheng M; Lee S; Banerjee K; Gangappa S; Kumaraguru U; Rouse BT
  • Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.
    J Virol Volume: 75 Page(s): 3077 - 3088
    04/01/2001 Authors: Deshpande SP; Lee S; Zheng M; Song B; Knipe D; Kapp JA; Rouse BT
  • Endothelial monocyte activating polypeptide II (EMAPII) suppresses angiogenesis and herpetic stromal keratitis.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 42 Page(s): S480 - S480
    03/15/2001 Authors: Zheng M; Schwarz MA; Deshpande S; Lee S; Torry DS; Rouse BT
  • Plasmid vaccine expressing CCR7 ligands attract sufficient dendritic cells to abrogate impaired immunity at site of immune induction
    FASEB JOURNAL Volume: 15 Page(s): A1034 - A1034
    03/08/2001 Authors: Eo SK; Kumaraguru U; Lee S; Rouse BT
  • Herpetic stromal keratitis: A possible autoimmune lesion but no involvement of molecular mimicry
    FASEB JOURNAL Volume: 15 Page(s): A1032 - A1032
    03/08/2001 Authors: Deshpande S; Zheng M; Lee S; Rouse BT
  • Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.
    J Virol Volume: 75 Page(s): 569 - 578
    01/01/2001 Authors: Eo SK; Lee S; Chun S; Rouse BT
  • On the mechanisms of T cell silencing by IL-10 DNA: direct and indirect inhibition of T cell functions.
    Cell Immunol Volume: 206 Page(s): 59 - 69
    11/25/2000 Authors: Eo SK; Chun S; Lee S; Rouse BT
  • Expression of IP-10 in the cornea controls the herpes virus induced immunoinflammatory ocular lesions
    JOURNAL OF LEUKOCYTE BIOLOGY Page(s): 26 - 26
    01/01/2000 Authors: Lee S; Eo SK; Chun S; Rouse BT
  • Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10.
    J Immunol Volume: 163 Page(s): 2393 - 2402
    09/01/1999 Authors: Chun S; Daheshia M; Lee S; Eo SK; Rouse BT
  • Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy.
    Cell Immunol Volume: 194 Page(s): 194 - 204
    06/15/1999 Authors: Chun S; Daheshia M; Lee S; Rouse BT
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements